ArticleJournal of ovarian research2025

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications.

Kai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.